Interacting Drugs |
Efavirenz, emtricitabine, and tenofovir vs Cisapride |
Security Level |
 |
Mechanism |
Cisapride: Efavirenz may enhance the QTc-prolonging effect of Cisapride. |
Management |
Avoid combination |
Efavirenz, emtricitabine, and tenofovir vs Cisapride
Post Review about Efavirenz, emtricitabine, and tenofovir vs Cisapride Click here to cancel reply.
Other Interactions of Efavirenz, emtricitabine, and tenofovir
Other Interactions of Cisapride
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.